UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 128

Sortiert nach

Genomic signatures define three subtypes of EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomes

Nature communications, 2021-11, Vol.12 (1), p.6450-6450, Article 6450

2021

Volltextzugriff (PDF)

Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial

Journal of clinical oncology, 2021-03, Vol.39 (7), p.713-722

2021

Volltextzugriff (PDF)

Frequency of the acquired resistant mutation T790 M in non-small cell lung cancer patients with active exon 19Del and exon 21 L858R: a systematic review and meta-analysis

BMC cancer, 2018-02, Vol.18 (1), p.148-148, Article 148

2018

Volltextzugriff (PDF)

A Novel Combined Conjugate Therapeutic Cancer Vaccine, Recombinant EGF-CRM197, in Patients With Advanced Solid Tumors: A Phase I Clinical Study

Frontiers in oncology, 2021-11, Vol.11, p.745699-745699

2021

Volltextzugriff (PDF)

Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia

Journal of thoracic oncology, 2023-04, Vol.18 (4), p.436-446

2023

Volltextzugriff (PDF)

Serum cytokine levels in patients with advanced non-small cell lung cancer： correlation with clinical outcome of erlotinib treatment

Chinese medical journal, 2013-10, Vol.126 (20), p.3931-3935

2013

Volltextzugriff (PDF)

Individualized Chemotherapy in Advanced NSCLC Patients Based on mRNA Levels of BRCA1 and RRM1

Chinese journal of cancer research, 2012-09, Vol.24 (3), p.226-231

2012

Volltextzugriff (PDF)

Erlotinib treatment for persistent spontaneous pneumothorax in non-small cell lung cancer： a case report

Chinese medical journal, 2010-12, Vol.123 (23), p.3501-3503

2010

Volltextzugriff (PDF)

High feasibility of liquid-based cytological samples for detection of EGFR mutations in Chinese patients with NSCLC

Asian Pacific journal of cancer prevention : APJCP, 2014-01, Vol.15 (18), p.7885-7889

2014

Volltextzugriff (PDF)

High Expression of Cathepsin E is Associated with the Severity of Airflow Limitation in Patients with COPD

Chronic obstructive pulmonary disease, 2016-03, Vol.13 (2), p.160-166

2016

Volltextzugriff (PDF)

Uncommon/rare oncogenic drivers in non‐small cell lung cancer: Consensus and contention

Medicine Advances, 2023-12, Vol.1 (4), p.293-305

2023

Volltextzugriff (PDF)

Efficacy of first-line chemotherapy affects the second-line setting response in patients with advanced non-small cell lung cancer

Asian Pacific journal of cancer prevention : APJCP, 2014-01, Vol.15 (16), p.6799-6804

2014

Volltextzugriff (PDF)

Evaluation of endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of hilar and mediastinal tumors

Zhonghua jiehe he huxi zazhi, 2013-01, Vol.36 (1), p.22

2013

Volltextzugriff (PDF)

Effect of Wnt signaling suppression on gefitinib in non small cell lung cancer cell lines

Zhonghua bing li xue za zhi, 2013-07, Vol.42 (7), p.455

2013

Volltextzugriff (PDF)

The ultrastructural features of sputum deposition and its value in the diagnosis of pulmonary alveolar proteinosis

Zhonghua jiehe he huxi zazhi, 2012-12, Vol.35 (12), p.887

2012

Volltextzugriff (PDF)

Impact of erlotinib treatment on symptoms and quality of life in patients with advanced non-small-cell lung cancer

Zhōnghuá zhŏngliú zázhì, 2008-06, Vol.30 (6), p.469

2008

Volltextzugriff (PDF)

The clinical diagnosis and analysis of pulmonary mucosa associated lymphoid tissue lymphoma

Zhonghua jiehe he huxi zazhi, 2007-03, Vol.30 (3), p.167

2007

Volltextzugriff (PDF)

High Feasibility of Liquid-Based Cytological Samples for Detection of EGFR Mutations in Chinese Patients with NSCLC

Asian Pacific journal of cancer prevention : APJCP, 2014, Vol.15 (18), p.7885-7889

2014

Volltextzugriff (PDF)

Efficacy of First-line Chemotherapy Affects the Second-Line Setting Response in Patients with Advanced Non-Small Cell Lung Cancer

Asian Pacific journal of cancer prevention : APJCP, 2014, Vol.15 (16), p.6799-6804

2014

Volltextzugriff (PDF)

P3.02c-025 Safety and Efficacy of Apatinib in Patients with Previously Heavily Treated Advanced Non-Squamous Non-Small-Cell Lung Cancer

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1286-S1287

2017

Volltextzugriff (PDF)

P3.02c-025 Safety and Efficacy of Apatinib in Patients with Previously Heavily Treated Advanced Non-Squamous Non-Small-Cell Lung Cancer: Topic: Targeted Therapy

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1286-S1287

2017

Volltextzugriff (PDF)

Non-destructive study of fruits using grating-based X-ray imaging

Nuclear science and techniques, 2017-02, Vol.28 (2), p.57-60, Article 24

2017

Volltextzugriff (PDF)

Novel Immuno-oncology Therapy: Current Status of Clinical Research and Prospect of Application

Zhongguo fei ai za zhi, 2017-09, Vol.20 (9), p.645-651

2017

Volltextzugriff (PDF)

Infliximab monotherapy for Chinese patients with moderate to severe plaque psoriasis： a randomized, double-blind, placebo-controlled multicenter trial

Chinese medical journal, 2012-06, Vol.125 (11), p.1845-1851

2012

Volltextzugriff (PDF)

High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/He N mice

世界胃肠病学杂志：英文版, 2015 (12), p.3527-3536

Xiu-Hua Peng Xiao-Nan Ren Li-Xiang Chen Bi-Sheng Shi Chun-Hua Xu Zhong Fang Xue Liu Jie-Liang Chen Xiao-Nan Zhang Yun-Wen Hu Xiao-Hui Zhou

2015

Volltextzugriff (PDF)

1 – 25 von 128

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(108)

Publikationsform

Artikel
(124)
Tagungsberichte
(4)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Genomic signatures define three subtypes of EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomes

Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial

Frequency of the acquired resistant mutation T790 M in non-small cell lung cancer patients with active exon 19Del and exon 21 L858R: a systematic review and meta-analysis

A Novel Combined Conjugate Therapeutic Cancer Vaccine, Recombinant EGF-CRM197, in Patients With Advanced Solid Tumors: A Phase I Clinical Study

Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia

Serum cytokine levels in patients with advanced non-small cell lung cancer： correlation with clinical outcome of erlotinib treatment

Individualized Chemotherapy in Advanced NSCLC Patients Based on mRNA Levels of BRCA1 and RRM1

Erlotinib treatment for persistent spontaneous pneumothorax in non-small cell lung cancer： a case report

High feasibility of liquid-based cytological samples for detection of EGFR mutations in Chinese patients with NSCLC

High Expression of Cathepsin E is Associated with the Severity of Airflow Limitation in Patients with COPD

Uncommon/rare oncogenic drivers in non‐small cell lung cancer: Consensus and contention

Efficacy of first-line chemotherapy affects the second-line setting response in patients with advanced non-small cell lung cancer

Evaluation of endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of hilar and mediastinal tumors

Effect of Wnt signaling suppression on gefitinib in non small cell lung cancer cell lines

The ultrastructural features of sputum deposition and its value in the diagnosis of pulmonary alveolar proteinosis

Impact of erlotinib treatment on symptoms and quality of life in patients with advanced non-small-cell lung cancer

The clinical diagnosis and analysis of pulmonary mucosa associated lymphoid tissue lymphoma

High Feasibility of Liquid-Based Cytological Samples for Detection of EGFR Mutations in Chinese Patients with NSCLC

Efficacy of First-line Chemotherapy Affects the Second-Line Setting Response in Patients with Advanced Non-Small Cell Lung Cancer

P3.02c-025 Safety and Efficacy of Apatinib in Patients with Previously Heavily Treated Advanced Non-Squamous Non-Small-Cell Lung Cancer

P3.02c-025 Safety and Efficacy of Apatinib in Patients with Previously Heavily Treated Advanced Non-Squamous Non-Small-Cell Lung Cancer: Topic: Targeted Therapy

Non-destructive study of fruits using grating-based X-ray imaging

Novel Immuno-oncology Therapy: Current Status of Clinical Research and Prospect of Application

Infliximab monotherapy for Chinese patients with moderate to severe plaque psoriasis： a randomized, double-blind, placebo-controlled multicenter trial

High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/He N mice

Suchergebnisse filtern